Skip to main content

Busulfan Injection

Last Updated: December 2, 2022
Status: Current

Products Affected - Description
    • Busulfan intravenous injection, Armas Pharmaceuticals, 6 mg/mL, 10 mL single dose vial, 8 count, NDC 72485-0210-08
    • Busulfan intravenous injection, Fresenius Kabi, 6 mg/mL, 10 mL single dose vial, 8 count, NDC 65219-0160-10 - discontinued
Reason for the Shortage
    • Amneal has busulfan injection available.
    • Armas Pharmaceuticals did not provide a reason for the shortage.
    • Athenex is not currently marketing busulfan injection.
    • Fresenius Kabi discontinued busulfan in early-2022.
    • Meitheal Pharmaceuticals has busulfan available.
    • Mylan Institutional has busulfan injection available.
    • Sagent has busulfan injection available.
    • Otsuka has Busulfex available.
Available Products
    • Busulfex intravenous injection, Otsuka America Pharmaceuticals, 6 mg/mL, 10 mL single dose vial, 8 count, NDC 59148-0070-91
    • Busulfan intravenous injection, Amneal, 6 mg/mL, 10 mL single dose vial, 8 count, NDC 70121-1244-07
    • Busulfan intravenous injection, Meitheal Pharmaceuticals, 6 mg/mL, 10 mL single dose vial, 8 count, NDC 71288-0116-11
    • Busulfan intravenous injection, Mylan (Viatris), 6 mg/mL, 10 mL single dose vial, 8 count, NDC 67457-0893-08
    • Busulfan intravenous injection, Sagent, 6 mg/mL, 10 mL single dose vial, 8 count, NDC 25021-0241-10

Estimated Resupply Dates

    • Armas has busulfan 6 mg/mL 10 mL vials on long-term back order and the company cannot estimate a release date.

Updated

Updated December 2, 2022 by Michelle Wheeler, PharmD, Drug Information Specialist. Created January 4, 2019 by Stephen Andrews, PharmD, BCPS, CPPS, Drug Information Specialist. © 2022, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.